P-1636. Real World Outpatient Utilization of Novel Anti-MRSA Antimicrobials: Patterns in Prescribing and Cost of Oral and Long-Acting Injectable Anti-MRSA Therapies in United States Medicaid Beneficiaries

Open Forum Infect Dis · 2025 · PMC11779378

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Delafloxacin utilization and total cost remained low while omadacycline had an increasing trend in utilization, total cost and APPC in the three years it was included.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.